Up­dat­ed: Welling­ton puts a bow on new $476M pri­vate biotech fund

Welling­ton Man­age­ment has a boat­load of new cash to play with af­ter clos­ing its sec­ond biotech-fo­cused fund.

The firm put to­geth­er a fund of about $476 mil­lion called Bio­med­ical In­no­va­tion II, it an­nounced Thurs­day morn­ing in a press re­lease, about three and a half years af­ter clos­ing its first fund. Welling­ton plans to make about 25 to 30 in­vest­ments with the fund, I-Hung Shih, the firm’s co-head of biotech pri­vate in­vest­ments, told End­points News on Thurs­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER